Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Temporal changes in myocardial salvage kinases during reperfusion following ischemia: studies involving the cardioprotective adipocytokine apelin.

Smith CC, Mocanu MM, Bowen J, Wynne AM, Simpkin JC, Dixon RA, Cooper MB, Yellon DM.

Cardiovasc Drugs Ther. 2007 Dec;21(6):409-14.

PMID:
17924178
2.

Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury.

Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM, Smith CC.

Basic Res Cardiol. 2007 Nov;102(6):518-28. Epub 2007 Aug 13.

PMID:
17694254
3.

Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signaling.

Efthymiou CA, Mocanu MM, Yellon DM.

J Cardiovasc Pharmacol. 2005 Mar;45(3):247-52.

PMID:
15725950
4.

Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.

Fan WJ, van Vuuren D, Genade S, Lochner A.

Basic Res Cardiol. 2010 Jul;105(4):495-511. doi: 10.1007/s00395-010-0086-3. Epub 2010 Feb 2.

PMID:
20127248
5.

Estrogen receptor beta mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia.

Wang M, Wang Y, Weil B, Abarbanell A, Herrmann J, Tan J, Kelly M, Meldrum DR.

Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R972-8. doi: 10.1152/ajpregu.00045.2009. Epub 2009 Feb 11.

6.

p38-MAPK and PKB/Akt, possible role players in red palm oil-induced protection of the isolated perfused rat heart?

Engelbrecht AM, Esterhuyse J, du Toit EF, Lochner A, van Rooyen J.

J Nutr Biochem. 2006 Apr;17(4):265-71. Epub 2005 May 31.

PMID:
16229999
7.

Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.

Zhu M, Feng J, Lucchinetti E, Fischer G, Xu L, Pedrazzini T, Schaub MC, Zaugg M.

Cardiovasc Res. 2006 Oct 1;72(1):152-62. Epub 2006 Jul 6.

PMID:
16901477
8.

Apelin-13 protects the brain against ischemia/reperfusion injury through activating PI3K/Akt and ERK1/2 signaling pathways.

Yang Y, Zhang X, Cui H, Zhang C, Zhu C, Li L.

Neurosci Lett. 2014 May 7;568:44-9. doi: 10.1016/j.neulet.2014.03.037. Epub 2014 Mar 29.

PMID:
24686182
9.

Apelin-13 protects the heart against ischemia-reperfusion injury through inhibition of ER-dependent apoptotic pathways in a time-dependent fashion.

Tao J, Zhu W, Li Y, Xin P, Li J, Liu M, Li J, Redington AN, Wei M.

Am J Physiol Heart Circ Physiol. 2011 Oct;301(4):H1471-86. doi: 10.1152/ajpheart.00097.2011. Epub 2011 Jul 29.

10.

Apelin protects heart against ischemia/reperfusion injury in rat.

Zeng XJ, Zhang LK, Wang HX, Lu LQ, Ma LQ, Tang CS.

Peptides. 2009 Jun;30(6):1144-52. doi: 10.1016/j.peptides.2009.02.010. Epub 2009 Feb 24.

PMID:
19463748
11.

Phosphorylation of phosphatidylinositol-3-kinase-protein kinase B and extracellular signal-regulated kinases 1/2 mediate reoxygenation-induced cardioprotection during hypoxia.

Milano G, von Segesser LK, Morel S, Joncic A, Bianciardi P, Vassalli G, Samaja M.

Exp Biol Med (Maywood). 2010 Mar;235(3):401-10. doi: 10.1258/ebm.2009.009153.

PMID:
20404059
12.
13.

Ischemic preconditioning protects by activating prosurvival kinases at reperfusion.

Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM.

Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H971-6. Epub 2004 Sep 9.

14.

Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties.

Kutala VK, Khan M, Mandal R, Ganesan LP, Tridandapani S, Kalai T, Hideg K, Kuppusamy P.

J Pharmacol Exp Ther. 2006 Jun;317(3):921-8. Epub 2006 Feb 8.

15.

Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice.

Morrison A, Yan X, Tong C, Li J.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H895-902. doi: 10.1152/ajpheart.00137.2011. Epub 2011 Jun 10.

16.

Insulin protects isolated hearts from ischemia/reperfusion injury: cross-talk between PI3-K/Akt and JNKs.

Liu HT, Zhang HF, Si R, Zhang QJ, Zhang KR, Guo WY, Wang HC, Gao F.

Sheng Li Xue Bao. 2007 Oct 25;59(5):651-9.

17.
18.

PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.

Bulhak AA, Jung C, Ostenson CG, Lundberg JO, Sjöquist PO, Pernow J.

Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H719-27. doi: 10.1152/ajpheart.00394.2008. Epub 2009 Jan 16.

19.
20.

Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.

Gonon AT, Widegren U, Bulhak A, Salehzadeh F, Persson J, Sjöquist PO, Pernow J.

Cardiovasc Res. 2008 Apr 1;78(1):116-22. doi: 10.1093/cvr/cvn017. Epub 2008 Jan 25.

PMID:
18222959

Supplemental Content

Support Center